(Q28551765)
Statements
MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism (English)
0 references
2016
0 references
11
0 references
5
0 references
e0152090
0 references
2 references
1 reference
1 reference